إعلان
إعلان
LAB
Standard BioTools Inc. Common Stock
1.54
USDبرعاية
+0.26
+20.70%
٠٨ يناير, ١٥:٥٤ UTC -5
مغلق
بعد الإغلاق
1.52
-0.02
-1.62%
تقارير أرباح LAB
النسبة الإيجابية المفاجئة
LAB تفوق 15 من 34 آخر التقديرات.
44%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$18.68M
/-$0.07
التغير الضمني من Q3 25 (Revenue/ EPS)
-4.43%
/-22.22%
التغير الضمني من Q4 24 (Revenue/ EPS)
-60.00%
/-22.22%
Standard BioTools Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, LAB reported earnings of -0.09 USD per share (EPS) for Q3 25, missing the estimate of -0.05 USD, resulting in a -61.87% surprise. Revenue reached 19.55 مليون, compared to an expected 18.18 مليون, with a 7.56% difference. The market reacted with a -4.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.07 USD, with revenue projected to reach 18.68 مليون USD, implying an نقصان of -22.22% EPS, and نقصان of -4.43% in Revenue from the last quarter.
الأسئلة الشائعة
What were Standard BioTools Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Standard BioTools Inc. Common Stock reported EPS of -$0.09, missing estimates by -61.87%, and revenue of $19.55M, 7.56% above expectations.
How did the market react to Standard BioTools Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.2%, changed from $1.19 before the earnings release to $1.14 the day after.
When is Standard BioTools Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Standard BioTools Inc. Common Stock's next earnings report?
Based on 4
المحللين, Standard BioTools Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $18.68M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان